Cochlear Limited (ASX:COH)

Market Cap	10.77B -38.8%
Revenue (ttm)	2.34B +1.3%
Net Income	345.30M -6.8%
EPS	5.27 -6.6%
Shares Out	65.40M
PE Ratio	31.25
Forward PE	24.94
Dividend	4.30 (2.61%)
Ex-Dividend Date	Mar 19, 2026

Volume	443,330
Average Volume	304,879
Open	166.83
Previous Close	166.83
Day's Range	164.62 - 170.34
52-Week Range	164.62 - 319.56
Beta	0.41
RSI	15.83
Earnings Date	Aug 18, 2026

About Cochlear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered i...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1981
• Employees: 5,500
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: COH

Financial Performance

In fiscal year 2025, Cochlear's revenue was 2.34 billion, an increase of 4.81% compared to the previous year's 2.24 billion. Earnings were 388.90 million, an increase of 9.00%.